Global Biosimulation Market 2024-2028
The biosimulation market is forecasted to grow by USD 4742.9 mn during 2023-2028, accelerating at a CAGR of 18.52% during the forecast period. The report on the biosimulation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in research funding and grants, rising demand for personalized medicine, and strategic initiatives by vendors.
Technavio's biosimulation market is segmented as below:
By End-user
- Pharmaceuticals and biotechnology companies
- Contract research and organizations
- Others
By Product
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the implementation of big data using mathematical models and simulation for drug discovery as one of the prime reasons driving the biosimulation market growth during the next few years. Also, leveraging mathematical modeling and simulation to improve generic drugs and presence of FDA-approved manufacturing facilities will lead to sizable demand in the market.
The report on the biosimulation market covers the following areas:
- Biosimulation market sizing
- Biosimulation market forecast
- Biosimulation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimulation market vendors that include Advanced Chemistry Development Inc., Allucent, Altair Engineering Inc., ANSYS Inc., Applied BioMath LLC., Cellworks Group Inc., Certara Inc., Chemical Computing Group ULC, Dassault Systemes SE, Genedata AG, INOSIM Software GmbH, Intelligen Inc., LifeTec Group, Physiomics PLC, Rosa and Co. LLC, Schrodinger Inc., Simulations Plus Inc., Thermo Fisher Scientific Inc., Via Science Inc., and Yokogawa Electric Corp.. Also, the biosimulation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.